Cancer cells are known to undergo metabolic reprogramming to sustain survival and rapid proliferation, however, it remains to be fully elucidated how oncogenic lesions coordinate the metabolic switch under various stressed conditions. Here we show that deprivation of
glucose or
glutamine, two major nutrition sources for
cancer cells, dramatically activated
serine biosynthesis pathway (SSP) that was accompanied by elevated cMyc expression. We further identified that cMyc stimulated SSP activation by transcriptionally upregulating expression of multiple SSP
enzymes. Moreover, we demonstrated that SSP activation facilitated by cMyc led to elevated
glutathione (GSH) production, cell cycle progression and
nucleic acid synthesis, which are essential for cell survival and proliferation especially under nutrient-deprived conditions. We further uncovered that
phosphoserine phosphatase (PSPH), the final rate-limiting
enzyme of the SSP pathway, is critical for cMyc-driven
cancer progression both in vitro and in vivo, and importantly, aberrant expression of PSPH is highly correlated with mortality in
hepatocellular carcinoma (HCC) patients, suggesting a potential causal relation between this cMyc-regulated
enzyme, or SSP activation in general, and
cancer development. Taken together, our results reveal that aberrant expression of cMyc leads to the enhanced SSP activation, an essential part of metabolic switch, to facilitate
cancer progression under nutrient-deprived conditions.